Lumentum Holdings Inc.: Form 10-Q for the period ended Apr 1, 2023
Filed with the SEC on May 9, 2023 and accepted by EDGAR at May 9, 2023, 13:23 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-04-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-01-01 to 2023-04-01 | $383.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-07-03 to 2023-04-01 | $1.40bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Gross profit | 3 months2023-01-01 to 2023-04-01 | $112.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2022-07-03 to 2023-04-01 | $479.4m | us-gaap:GrossProfit |
| Research and development | 3 months2023-01-01 to 2023-04-01 | $85.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2022-07-03 to 2023-04-01 | $233.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-01-01 to 2023-04-01 | $76.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-07-03 to 2023-04-01 | $280.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-01-01 to 2023-04-01 | −$51.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-07-03 to 2023-04-01 | −$59.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-01-01 to 2023-04-01 | $8.7m | us-gaap:InterestExpense |
| Interest expense | 9 months2022-07-03 to 2023-04-01 | $26.1m | us-gaap:InterestExpense |
| Income tax | 3 months2023-01-01 to 2023-04-01 | −$9.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-07-03 to 2023-04-01 | $14.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-01-01 to 2023-04-01 | −$39.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-07-03 to 2023-04-01 | −$71.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-01-01 to 2023-04-01 | −$0.57 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-07-03 to 2023-04-01 | −$1.05 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-01-01 to 2023-04-01 | −$0.57 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-07-03 to 2023-04-01 | −$1.05 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-01-01 to 2023-04-01 | 68,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-07-03 to 2023-04-01 | 68,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-07-03 to 2023-04-01 | $130.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-07-03 to 2023-04-01 | $92.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2022-07-03 to 2023-04-01 | $35.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-04-01 | $549.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-04-01 | $2.46bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-04-01 | $4.35bn | us-gaap:Assets |
| Current liabilities | At period end2023-04-01 | $768.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-04-01 | $2.82bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-04-01 | $1.90bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2023-04-01 | $426.2m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-04-01 | $1.54bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-23-016653. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.